What we know about the Covid variant EG.5 dubbed ‘Eris’
The World Health Organisation declared the variant of interest, with cases reported in 51 countries.
The World Health Organisation declared the variant of interest, with cases reported in 51 countries.
Health 25 August 2023, 6:39 pm 1 minute Reuters exclusively reported that Novo Nordisk has hired Thermo Fisher as its second contract manufacturer for its hugely popular weight-loss drug Wegovy. Novo Chief Financial Officer Karsten Munk Knudsen told Reuters in May the company had signed up a second contract manufacturer in the United States, but…
Investors are contemplating where and when the next big obesity drug deal will occur. At the moment, Novo Nordisk and Eli Lilly have the growing obesity drug market all to themselves. But given the potential size of this opportunity, which some have put at more than $100 billion by 2030 , other pharmaceuticals companies —…
“I have contacts, but I wear daily ones, and at the end of the day I can make all the excuses I want. I don’t take them out. I sleep in them. It’s not healthy. You’re supposed to change them,” Spelling told her co-star. Since one-third of people wear contact lenses, there’s a possibility that…
Image source, Getty Images By Jennifer Clarke BBC News Prime Minister Rishi Sunak robustly defended the Eat Out to Help Out Scheme he implemented as chancellor during the pandemic in his evidence to the Covid inquiry. Earlier, former Prime Minister Boris Johnson admitted he had underestimated the scale and the challenge of coronavirus. The inquiry’s…
BuzzFeed may collect a share of sales or other compensation from the links on this page if you decide to shop from them. All products were independently selected by our editors, and the prices were accurate and items in stock at the time of publication. In general, spring is wonderful. In many parts of the…
An exterior view of Moderna’s clinical manufacturing facility. David L. Ryan | Boston Globe | Getty Images Moderna and Merck‘s experimental cancer vaccine, when used in combination with Merck’s blockbuster therapy Keytruda, reduced the risk of death or relapse in patients with the most deadly form of skin cancer by half after roughly three years,…